Cite

    Melikian, N. et al. (n.d.). Metabolic syndrome is a key determinant of coronary microvascular function in patients with stable coronary disease and optimal low-density lipoprotein cholesterol levels undergoing percutaneous coronary intervention. Heart. p. 81. [Online].